PERSONALIZED MULTI-EPITOPE PEPTIDE VACCINE DESIGN TARGETING NOTCH1 MUTATIONS IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL): A COMPREHENSIVE IMMUNOINFORMATICS ANALYSIS

36 | FREQUENCY OF FUSION GENES AND THEIR CLINICAL IMPACTS IN CHINESE PEDIATRIC PATIENTS WITH T‐CELL LYMPHOBLASTIC LYMPHOMA
von: Y. Li, et al.
Veröffentlicht: (2025)

558 | PREFERENCES FOR TREATMENT IN FIRST‐LINE CHRONIC LYMPHOCYTIC LEUKEMIA: A MULTI‐CRITERIA DECISION ANALYSIS IN ITALY
von: P. Sportoletti, et al.
Veröffentlicht: (2025)

REDEFINING SURGICAL COMPLEXITY IN ACUTE CHOLECYSTITIS: A MULTI-PARAMETRIC ANALYSIS OF PREOPERATIVE PREDICTORS AND OPERATIVE TIME THRESHOLDS
von: Ahmad Ali Ali*, General Surgery
Veröffentlicht: (2026)

739 | ADDRESSING HYPERCALCEMIA IN ADULT T‐CELL LEUKEMIA/LYMPHOMA
von: M. Srinivasan, et al.
Veröffentlicht: (2025)

300 | DIFFUSE LARGE B‐CELL LYMPHOMA IN BRAZIL: A COMPREHENSIVE ANALYSIS OF SOCIODEMOGRAPHIC PATTERNS
von: G. Duffles, et al.
Veröffentlicht: (2025)

119 | LIS22: AN EFFECTIVE MULTIMODAL POLYCLONAL ANTIBODY TARGETING T‐CELL MALIGNANCIES
von: C. Ciron, et al.
Veröffentlicht: (2025)

601 | TARGETING NAMPT AND BTK IN MANTLE CELL LYMPHOMA: TP53‐DEPENDENT SYNERGISTIC THERAPY
von: Y. Liu, et al.
Veröffentlicht: (2025)

389 | THE OUTCOME OF ADULT T‐CELL LEUKEMIA/LYMPHOMA IN REAL WORLD SETTING: INSIGHTS FROM THE T‐CELL PROJECT 2.0
von: C. S. Chiattone, et al.
Veröffentlicht: (2025)

431 | EZH2 GAIN‐OF‐FUNCTION MUTATIONS CONFER EVEROLIMUS SENSITIVITY IN DIFFUSE LARGE B CELL LYMPHOMA
von: B. W. Tan, et al.
Veröffentlicht: (2025)

185 | COMPREHENSIVE ANALYSIS IDENTIFIES DISTINCT PATTERNS OF MOLECULAR ALTERATIONS ACROSS AGE GROUPS IN DIFFUSE LARGE B‐CELL LYMPHOMA
von: M. Uppal, et al.
Veröffentlicht: (2025)

CIRCULATING VACCINE-DERIVED POLIOVIRUS TYPE 2 OUTBREAK IN SIERRA LEONE, DECEMBER 2020: ANALYSIS OF THE INITIAL THREE CASES
von: Mansaray, Aisha Fatmata Jalloh, et al.
Veröffentlicht: (2025)

831 | A PHASE 1, MULTICENTER, FIRST‐IN‐HUMAN TRIAL OF GCC2005, AN ALLOGENEIC CAR‐NK CELL THERAPY TARGETING CD5, IN PATIENTS WITH RELAPSED/REFRACTORY NK AND T‐CELL MALIGNANCIES
von: W. S. Kim, et al.
Veröffentlicht: (2025)

GENE-TARGETING IN DROSOPHILA VALIDATED
von: GLOOR, G .B
Veröffentlicht: (2001)

310 | A MULTI‐CENTER REAL‐LIFE ANALYSIS ON PATIENTS WITH LARGE B‐CELL LYMPHOMA AFTER FAILURE OF CAR‐T CELLS THERAPY
von: M. Farina, et al.
Veröffentlicht: (2025)

428 | THE SYNTHETIC PEPTIDE CIGB‐552 INDUCES CELL DEATH AND ENHANCES IBRUTINIB EFFICACY IN MARGINAL ZONE LYMPHOMA, INCLUDING DRUG‐RESISTANT MODELS
von: M. Carpio, et al.
Veröffentlicht: (2025)

865 | THE IMPACT OF RADIOTHERAPY ON SURVIVAL IN YOUNGER PATIENTS WITH ADVANCED AGGRESSIVE B‐CELL LYMPHOMA IN THE RITUXIMAB ERA: A MULTI‐CENTER RETROSPECTIVE ANALYSIS
von: L. Wang, et al.
Veröffentlicht: (2025)

45 | MULTI‐TARGETED THERAPY WITH ViPOR IN MANTLE CELL LYMPHOMA (MCL); UPDATED ANALYSIS OF EFFICACY AND MINIMAL RESIDUAL DISEASE (MRD)
von: C. Melani, et al.
Veröffentlicht: (2025)

The embryonic and larvae developments of Tomato Anemonefish (Amphiprion frenatus Brevoort, 1856) in Khanh Hoa coast
von: Ha, Le Thi Loc
Veröffentlicht: (2002)

The effects of certain ecological factors on the growth of Tetraselmis sp. in laboratory
von: Ha, Le Thi Loc
Veröffentlicht: (2000)

PREVALENCE AND CORRELATES OF SUBCUTANEOUS VERSUS INTRADERMAL MPOX VACCINE DELIVERY
Veröffentlicht: (2024)

645 | REAL‐WORLD TREATMENT PATTERNS AND SURVIVAL OUTCOMES OF DIFFUSE LARGE B CELL LYMPHOMA: A RETROSPECTIVE ANALYSIS FROM A COMPREHENSIVE PORTUGUESE CANCER CENTER
von: I. O. Ramos, et al.
Veröffentlicht: (2025)

MODERN REQUIREMENTS FOR OIL AND GAS INDUSTRY PROFESSIONALS: A COMPREHENSIVE ANALYSIS
von: Tojiboeva, Madinakhon
Veröffentlicht: (2025)

316 | MULTI‐TARGETED THERAPY WITH VIPOR‐P IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: UPDATED ANALYSIS OF EFFICACY AND MINIMAL RESIDUAL DISEASE
von: C. Melani, et al.
Veröffentlicht: (2025)

DESIGN OF A RESORT AND MULTI-STORY HOUSES (RECREATION ZONE) IN SALINATOUS SOIL AREAS.
von: Mengatova, Khurshida, et al.
Veröffentlicht: (2025)

ALDH1 AND ALCAM AS EMERGING BIOMARKERS IN PERSONALIZED RECTAL CANCER THERAPY
von: Ribas Filho , Jurandir Marcondes, et al.
Veröffentlicht: (2025)

DESIGN AND IMPLEMENTATION OF A PEM FUEL CELL EMULATOR FOR STATIC AND DYNAMIC BEHAVIOR
von: CARLOS ANDRÉS RAMOS-PAJA
Veröffentlicht: (2011)

SPECIAL ECONOMIC ZONES IN PAKISTAN: A COMPREHENSIVE ANALYSIS OF POLICY, PERFORMANCE, AND PROSPECTS
von: Muhammad Asad, Dr. Muhammad Fahim Khan
Veröffentlicht: (2025)

Compartment-specific estimation of T2 and T2* with diffusion-PEPTIDE MRI
von: Gong, Ting, et al.
Veröffentlicht: (2024)

376 | CD20‐NEGATIVE RELAPSED/REFRACTORY MATURE B‐CELL NON‐HODGKIN LYMPHOMA (B‐NHLs) AND MATURE B‐CELL LEUKEMIA IN CHILDREN, ADOLESCENT AND YOUNG ADULTS: A RETROSPECTIVE REVIEW
von: L. Vinti, et al.
Veröffentlicht: (2025)

805 | PRE‐CLINICAL DEVELOPMENT OF CAR‐T CELLS TARGETING A LYTIC EBV ANTIGEN gp350 FOR THERAPY OF EBV‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA
von: Y. Li, et al.
Veröffentlicht: (2025)

GAME THEORETICAL MODELING OF VACCINE HESITANCY AND ITS IMPACT ON PUBLIC HEALTH CAMPAIGNS
von: A. Dinesh Kumar, Jerryson Ameworgbe Gidisu, Mbonigaba Celestin & M. Vasuki
Veröffentlicht: (2026)

SCENARIO ORAL ROTAVIRUS VACCINE IN HUMAN PERIPHERAL REGION OF RIO DE JANEIRO
von: Viviane da Silva Magalhães
Veröffentlicht: (2013)

824 | R‐CHOP WITH SINTILIZUMAB IN FIRST‐LINE TREATMENT OF LARGE B‐CELL LYMPHOMA PATIENTS WITH TP53 MUTATIONS AND PD‐L1 EXPRESSION: A RANDOMIZED, MULTICENTER CLINICAL STUDY
von: Y. Che, et al.
Veröffentlicht: (2025)

GENOMIC DETECTION OF CORONAVIRIDAE IN RODENTS TARGETING THE RDRP GENE
von: Ayesha Jahangir*1, Qurratul Ain Leghari2, Aadab Akhtar3, Muhammad Bilal4, Waqas Mahmood5, Amna Masood6, Raheela Sarwar7, Sobia Nawaz8, Abdullah Rehman9, Ayesha Jabeen10, Abida Parveen11
Veröffentlicht: (2025)

539 | THE LANDSCAPE OF CHRONIC LYMPHOCYTIC LEUKEMIA IN EGYPT: RESULTS FROM THE REGIONAL CREEK STUDY SUBGROUP ANALYSIS
von: G. Fathy, et al.
Veröffentlicht: (2025)

GENETIC ANALYSIS OF THE MAMMALIAN CELL DEATH MACHINERY
von: JOZA, N. ,ET AL
Veröffentlicht: (2002)